Depressive And Anxiety Symptoms In Women With Polycystic Ovary Syndrome: A Meta-Analysis

    May 2026 in “ Journal of Clinical Medicine ”
    Katarzyna Stańczyk, Olga Łopacińska, Dominika Kędzia, O. Gawlik-Kotelnicka
    Image
    Studysummary This meta-analysis found a significantly higher prevalence of depressive symptoms in women with PCOS compared to a control group, with 42.11% versus 13.62% according to the BDI assessment, highlighting the need for psychiatric evaluation and support for women with this syndrome. Our plain-language summary of this paper — not a Tressless recommendation.
    This meta-analysis examined the prevalence of depressive and anxiety symptoms in women with polycystic ovary syndrome (PCOS) by analyzing data from 35 studies involving 5,857 women. The results showed that women with PCOS had a significantly higher prevalence of depressive symptoms compared to controls, with rates of 42.11% vs. 13.62%. Anxiety symptoms were also more prevalent in the PCOS group, with 48.25% compared to 31.40% in controls, although this difference was not statistically significant. The study underscores the importance of psychiatric evaluations and support for women with PCOS due to their increased risk of depressive symptoms, highlighting the psychological burden associated with PCOS and the need for targeted clinical interventions.
    Discuss this study in the Community →

    Research cited in this study

    13 / 13 results